An exploratory analysis of a phase 3 COVID-19 trial found that a composite score combining baseline interleukin-6 levels and ...
Welltica+ on MSN
Explained: COVID-19
More than three years after the global COVID-19 health emergency ended, the virus continues to cause hospitalisations and ...
Among 414 nurses deployed from Fujian to Hubei during the early COVID-19 response, sleep-quality and sleepiness ...
By highlighting bone density screening, Fontanez hopes to encourage greater awareness of the role imaging can play in preventive healthcare and the importance of discussing individual screening needs ...
In AD, BioVie has conducted Phase 2 and Phase 3 trials. Preliminary data from these trials suggest improvements in cognition and biomarkers, supporting further trials to evaluate its potential as a ...
Just beyond Yellowstone National Park’s remote northeast corner, an unassuming log sign blends into the backdrop of lodgepole ...
The "response to infectious diseases" that society experienced during the COVID-19 era is highly suggestive when considering ...
Researchers found five events, including Russia’s invasion of Ukraine, caused serious damage to mental wellbeing across UK ...
BioVie Inc. announced the presentation of results from the Phase 2 ADDRESS-LC study (NCT06847191) evaluating bezisterim (NE3107) in patients with Long COVID at the 151st Annual Meeting of the American ...
The Mississippi State Board of Health met Wednesday for its quarterly meeting, where state health officials outlined progress ...
COVID-19 accelerated efforts to develop faster, more efficient ways of manufacturing high-quality RNA sequences.
The confusion, the fear, the desperate race to understand a brand-new pathogen that was upending lives globally? What if I told you that the very same genetic technology that helped us identify and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results